These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25983163)

  • 1. When and how to use BRS in bifurcations?
    Stankovic G; Lassen JF
    EuroIntervention; 2015; 11 Suppl V():V185-7. PubMed ID: 25983163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technology limitations of BRS in bifurcations.
    Fox J; Hossainy S; Rapoza R; Serruys PW
    EuroIntervention; 2015; 11 Suppl V():V155-8. PubMed ID: 25983156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioresorbable Scaffolds for the Management of Coronary Bifurcation Lesions.
    Kawamoto H; Ruparelia N; Tanaka A; Chieffo A; Latib A; Colombo A
    JACC Cardiovasc Interv; 2016 May; 9(10):989-1000. PubMed ID: 27198679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paving the way to a bioresorbable technology: Development of the absorb BRS program.
    Perkins LE; Kossuth MB; Fox JC; Rapoza RJ
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):1-9. PubMed ID: 27797462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioresorbable Scaffolds: Clinical Outcomes and Considerations.
    Capodanno D
    Interv Cardiol Clin; 2016 Jul; 5(3):357-363. PubMed ID: 28582033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.
    Ielasi A; Tespili M
    Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First ad hoc bioresorbable vascular scaffold bench test: a glimpse into percutaneous bifurcation interventions.
    Sgueglia GA; D'Errico F; Gioffrè G; De Santis A; Gaspardone A
    Int J Cardiol; 2014 Apr; 172(3):604-6. PubMed ID: 24491860
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of BRS in bifurcations.
    Kraak RP; Grundeken MJ; Onuma Y; Tu S; Wykrzykowska JJ; Chevalier B; Ormiston J; Serruys PW
    EuroIntervention; 2015; 11 Suppl V():V188-92. PubMed ID: 25983164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings.
    Lassen JF; Holm NR; Stankovic G; Lefèvre T; Chieffo A; Hildick-Smith D; Pan M; Darremont O; Albiero R; Ferenc M; Louvard Y
    EuroIntervention; 2014 Sep; 10(5):545-60. PubMed ID: 25256198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease.
    Dziewierz A; Dudek D
    Kardiol Pol; 2018; 76(7):1043-1054. PubMed ID: 30251247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging and functional assessment of bioresorbable scaffolds.
    Pighi M; Tanguay JF; L'allier PL
    Minerva Cardioangiol; 2016 Aug; 64(4):442-61. PubMed ID: 27195663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design Principles of Bioresorbable Polymeric Scaffolds.
    Kossuth MB; Perkins LEL; Rapoza RJ
    Interv Cardiol Clin; 2016 Jul; 5(3):349-355. PubMed ID: 28582032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography.
    Attizzani GF; Ohno Y; Capranzano P; La Manna A; Francaviglia B; Grasso C; Sgroi C; Tamburino C; Longo G; Fujino Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Dec; 170(2):e33-5. PubMed ID: 24210418
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioresorbable scaffolds in daily clinical routine: a practical review of all-comers results.
    Wiebe J; Hamm CW; Nef HM
    Curr Opin Cardiol; 2015 Nov; 30(6):650-6. PubMed ID: 26447503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EuroIntervention coronary bifurcation treatment supplement.
    Stankovic G; Lassen JF; Hildick-Smith D; Lefèvre T; Louvard Y; Gwon HC; Grundeken MJ
    EuroIntervention; 2015; 11 Suppl V():V9-11. PubMed ID: 25983181
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioresorbable vascular scaffold in patients with complex coronary artery disease.
    Tamburino CI; Capranzano P; Longo G; Immè S; Tamburino G; Scalia M; Condorelli A; Francaviglia B; LA Manna A; Sgroi C; Grasso C; DI Salvo ME; Capodanno D; Tamburino C
    Minerva Cardioangiol; 2016 Aug; 64(4):481-6. PubMed ID: 27128353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioresorbable Vascular Scaffolds in Coronary Bifurcation Lesions: Only in Expert Hands.
    Colleran R; Byrne RA
    Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):543-6. PubMed ID: 27157886
    [No Abstract]   [Full Text] [Related]  

  • 19. [Research Progress of Bioresorbable Scaffold].
    Liu Q; Cui S; Zhao Q; Chen M; Zheng B; Huo Y
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 Sep; 41(5):357-361. PubMed ID: 29862725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.